54 733
Pill imprint 54 733 has been identified as Morphine sulfate 15 mg.
Morphine is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Morphine 15 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Morphine sulfate Images
- Imprint:
-
54 733
- Strength:
- 15 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Roxane Laboratories, Inc.
- National Drug Code (NDC):
- 00054-4582
Advertisement
More Morphine Sulfate resources
- Morphine
- Morphine Concentrate (Wolters Kluwer)
- Morphine Extended-Release Capsules (Wolters Kluwer)
- Morphine Immediate-Release (Wolters Kluwer)
- Morphine Immediate-Release Tablets (Wolters Kluwer)
- Morphine Soluble Tablets (Wolters Kluwer)
- Morphine Solution (Wolters Kluwer)
- Morphine Suppositories (Wolters Kluwer)
- Morphine Sustained-Release Tablets (Wolters Kluwer)
- Morphine IR (Cerner Multum)
- morphine (Cerner Multum)
- DepoDur (Micromedex) - Includes Dosage Information
- morphine (Micromedex) - Includes Dosage Information
- morphine Epidural (Micromedex) - Includes Dosage Information
- morphine Injection (Micromedex) - Includes Dosage Information
- Morphine Sulfate (AHFS DI)
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Injection PF (FDA)
- Morphine Oral Solution (FDA)
- Morphine Sulfate (FDA)
- Morphine Sulfate Injection (FDA)
- Morphine Sulfate Solution, Concentrate (FDA)
- Opium Tincture (FDA)
- Morphine Sulfate (Wolters Kluwer)
Search Again
